659 related articles for article (PubMed ID: 29547971)
1. Potential targets for next generation antimicrobial glycoconjugate vaccines.
Micoli F; Costantino P; Adamo R
FEMS Microbiol Rev; 2018 May; 42(3):388-423. PubMed ID: 29547971
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies for development of next-generation glycoconjugate vaccines.
Avci FY
Curr Top Med Chem; 2013; 13(20):2535-40. PubMed ID: 24066893
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance.
Del Bino L; Østerlid KE; Wu DY; Nonne F; Romano MR; Codée J; Adamo R
Chem Rev; 2022 Oct; 122(20):15672-15716. PubMed ID: 35608633
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate-Based Vaccines: An Overview.
Hütter J; Lepenies B
Methods Mol Biol; 2015; 1331():1-10. PubMed ID: 26169731
[TBL] [Abstract][Full Text] [Related]
5. Glycoconjugate vaccines: current approaches towards faster vaccine design.
Micoli F; Del Bino L; Alfini R; Carboni F; Romano MR; Adamo R
Expert Rev Vaccines; 2019 Sep; 18(9):881-895. PubMed ID: 31475596
[No Abstract] [Full Text] [Related]
6. Glycoconjugate vaccines: an update.
Vella M; Pace D
Expert Opin Biol Ther; 2015 Apr; 15(4):529-46. PubMed ID: 25496172
[TBL] [Abstract][Full Text] [Related]
7. Glycoconjugate vaccines against antimicrobial resistant pathogens.
Sorieul C; Dolce M; Romano MR; Codée J; Adamo R
Expert Rev Vaccines; 2023; 22(1):1055-1078. PubMed ID: 37902243
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharides from Burkholderia species as targets for vaccine development, immunomodulation and chemical synthesis.
Cloutier M; Muru K; Ravicoularamin G; Gauthier C
Nat Prod Rep; 2018 Dec; 35(12):1251-1293. PubMed ID: 30023998
[TBL] [Abstract][Full Text] [Related]
9. Recent mechanistic insights on glycoconjugate vaccines and future perspectives.
Berti F; Adamo R
ACS Chem Biol; 2013 Aug; 8(8):1653-63. PubMed ID: 23841819
[TBL] [Abstract][Full Text] [Related]
10. Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.
Berti F; De Ricco R; Rappuoli R
Molecules; 2018 Jun; 23(6):. PubMed ID: 29865239
[TBL] [Abstract][Full Text] [Related]
11. Glycoconjugate vaccines.
Pace D
Expert Opin Biol Ther; 2013 Jan; 13(1):11-33. PubMed ID: 22992106
[TBL] [Abstract][Full Text] [Related]
12. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
Adamo R
Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
[TBL] [Abstract][Full Text] [Related]
13. Synthetic carbohydrate-based vaccines: challenges and opportunities.
Mettu R; Chen CY; Wu CY
J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
[TBL] [Abstract][Full Text] [Related]
14. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production.
Dow JM; Mauri M; Scott TA; Wren BW
Expert Rev Vaccines; 2020 Jun; 19(6):507-527. PubMed ID: 32627609
[TBL] [Abstract][Full Text] [Related]
15. Glycoconjugate vaccines: future combinations.
Paradiso PR; Lindberg AA
Dev Biol Stand; 1996; 87():269-75. PubMed ID: 8854027
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in lipopolysaccharide-based glycoconjugate vaccines.
Zhu H; Rollier CS; Pollard AJ
Expert Rev Vaccines; 2021 Dec; 20(12):1515-1538. PubMed ID: 34550840
[TBL] [Abstract][Full Text] [Related]
17. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
Cuccui J; Wren B
J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
[TBL] [Abstract][Full Text] [Related]
18. The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline.
Frost I; Sati H; Garcia-Vello P; Hasso-Agopsowicz M; Lienhardt C; Gigante V; Beyer P
Lancet Microbe; 2023 Feb; 4(2):e113-e125. PubMed ID: 36528040
[TBL] [Abstract][Full Text] [Related]
19. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].
Mulard L
Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in bacterial conjugate vaccines.
Goldblatt D
J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
